L’adénocarcinome du col utérin : particularités diagnostiques et thérapeutiques

Vandenbroucke, L.; Robert, Aude; Lavoué, Vincent; Foucher, Fabrice; Henno, Sébastien; Lévèque, Jean

doi:10.1016/j.jgyn.2012.07.003

Cited by 5 publications

(1 citation statement)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The glandular epithelium is also vulnerable to HPV infections, especially by HPV-18, which may cause adenocarcinoma (ADC), while HPV-16 is being identified more often in SCC than in ADC (63). The adenocarcinoma of the uterine cervix accounts for 10 to 20% of the premalignant and malignant lesions and is different from the cervical intraepithelial neoplasia and invasive squamous cell carcinoma (71).…”

Section: Clinical Manifestations Of Human Papillomavirus Infectionmentioning

confidence: 99%

Genital human papillomavirus infections

Kaliterna¹

2018

Front Biosci

View full text Add to dashboard Cite

Human papillomavirus (HPV) infections can have clinical presentations from self-limited benign growth in the skin and mucosal epithelia to malignant growth. HPV infects basal epithelial cells (undifferentiated keratinocytes) of the squamous-columnar junction, especially of the cervix. Although today we understand HPV oncogenesis very well, we have very powerful methods of diagnosis, treatment and prevention of HPV related precancerous lesions, however, more than 270,000 women annually die from cervical cancer worldwide. Integrating HPV vaccination with new, more sensitive, cervical screening assays as part of routine preventive care will improve healthcare for all women. The availability of prophylactic HPV vaccines has provided powerful tools for primary prevention of cervical cancer and other HPV-associated diseases. Secondary prevention through primary high-risk HPV (hr-HPV) testing has the potential to further reduce morbidity and mortality of cervical cancer. However, to achieve the maximum benefit of screening, there is need to continue to identify women who are either unscreened or under-screened. Synergies between HPV vaccination and HPV screening is recommended to improve the effectiveness and cost-effectiveness of prevention HPV-related disease.

show abstract

Section: Clinical Manifestations Of Human Papillomavirus Infectionmentioning

confidence: 99%